| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
105,812 |
94,396 |
$64.90M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
50,654 |
45,688 |
$36.16M |
| L8699 |
Prosthetic implant, not otherwise specified |
4,377 |
2,760 |
$11.70M |
| J9271 |
Injection, pembrolizumab, 1 mg |
3,887 |
1,373 |
$10.96M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
8,224 |
8,084 |
$5.31M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
2,886 |
2,863 |
$4.97M |
| S5102 |
Day care services, adult; per diem |
55,320 |
3,311 |
$4.45M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
30,338 |
2,292 |
$4.01M |
| 0360 |
|
28,764 |
12,986 |
$3.62M |
| J9312 |
Injection, rituximab, 10 mg |
2,470 |
1,080 |
$3.40M |
| J3490 |
Unclassified drugs |
221,940 |
87,612 |
$2.92M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13,758 |
13,207 |
$2.65M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
20,247 |
11,928 |
$2.37M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
66,392 |
56,435 |
$2.26M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
1,287 |
906 |
$2.18M |
| 77523 |
|
1,616 |
151 |
$2.14M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13,045 |
12,723 |
$2.07M |
| J9035 |
Injection, bevacizumab, 10 mg |
1,302 |
473 |
$1.98M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
86,501 |
17,039 |
$1.95M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,509 |
6,997 |
$1.93M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
19,716 |
19,120 |
$1.93M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
1,045 |
651 |
$1.93M |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
1,656 |
431 |
$1.88M |
| 99221 |
|
10,986 |
10,727 |
$1.81M |
| J7050 |
Infusion, normal saline solution, 250 cc |
96,536 |
36,060 |
$1.58M |
| J9299 |
Injection, nivolumab, 1 mg |
818 |
212 |
$1.52M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18,036 |
16,554 |
$1.50M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,592 |
3,382 |
$1.41M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
4,547 |
4,489 |
$1.38M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,965 |
3,812 |
$1.35M |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
1,705 |
1,216 |
$1.28M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
41,357 |
29,202 |
$1.17M |
| 95782 |
|
1,100 |
1,083 |
$1.05M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
39,895 |
36,454 |
$997K |
| 99070 |
|
297,203 |
107,310 |
$979K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15,299 |
10,523 |
$951K |
| 80053 |
Comprehensive metabolic panel |
145,831 |
120,214 |
$941K |
| 0710 |
|
23,804 |
17,907 |
$936K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
17,960 |
1,764 |
$899K |
| 95713 |
|
1,082 |
1,078 |
$888K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,819 |
2,086 |
$815K |
| 77334 |
|
2,891 |
1,671 |
$810K |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,794 |
15,062 |
$769K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,033 |
5,958 |
$760K |
| J0897 |
Injection, denosumab, 1 mg |
1,122 |
880 |
$736K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
35,006 |
27,058 |
$708K |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
1,498 |
146 |
$707K |
| 95811 |
|
2,388 |
2,355 |
$681K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
36,819 |
29,155 |
$655K |
| 74183 |
|
2,051 |
2,027 |
$621K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
699 |
483 |
$615K |
| J2704 |
Injection, propofol, 10 mg |
36,147 |
25,350 |
$612K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,336 |
12,500 |
$610K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
27,742 |
24,730 |
$610K |
| 77300 |
|
1,775 |
1,460 |
$600K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,115 |
507 |
$594K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,919 |
1,879 |
$588K |
| 90945 |
|
11,226 |
412 |
$587K |
| 0456 |
|
21,011 |
19,324 |
$586K |
| 97750 |
|
12,049 |
5,989 |
$583K |
| 77417 |
|
13,747 |
2,250 |
$565K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,765 |
3,495 |
$538K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44,537 |
33,992 |
$535K |
| 0510 |
|
14,272 |
11,151 |
$515K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,400 |
1,366 |
$507K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
10,628 |
3,620 |
$505K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,635 |
1,497 |
$489K |
| 72141 |
|
1,393 |
1,369 |
$488K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
114,102 |
94,674 |
$484K |
| 71250 |
|
3,710 |
3,601 |
$478K |
| 71046 |
Radiologic examination, chest; 2 views |
38,330 |
35,992 |
$476K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
44,541 |
38,495 |
$475K |
| 96415 |
|
8,474 |
5,405 |
$461K |
| 77295 |
|
756 |
708 |
$450K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
6,948 |
6,866 |
$447K |
| 0516 |
|
13,777 |
12,258 |
$446K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13,423 |
11,472 |
$440K |
| 72197 |
|
1,495 |
1,485 |
$427K |
| 96417 |
|
6,141 |
3,847 |
$417K |
| 93325 |
|
4,851 |
4,743 |
$399K |
| 95700 |
|
1,327 |
1,325 |
$390K |
| 54161 |
|
2,361 |
2,269 |
$389K |
| 86923 |
|
4,894 |
3,303 |
$383K |
| 77336 |
|
5,348 |
2,313 |
$369K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
25,239 |
22,559 |
$360K |
| 72156 |
|
571 |
571 |
$354K |
| 97799 |
|
13,857 |
4,016 |
$331K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,136 |
2,116 |
$326K |
| 77412 |
|
4,990 |
615 |
$323K |
| 77290 |
|
2,101 |
1,530 |
$322K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
43,299 |
39,455 |
$310K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,682 |
4,559 |
$304K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
12,556 |
12,382 |
$301K |
| 95806 |
|
2,276 |
2,263 |
$300K |
| 85027 |
|
59,218 |
50,769 |
$293K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
20,738 |
17,603 |
$293K |
| 93976 |
|
5,148 |
4,905 |
$291K |
| 70491 |
|
1,963 |
1,931 |
$284K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
7,569 |
7,269 |
$283K |
| J0185 |
Injection, aprepitant, 1 mg |
3,512 |
1,465 |
$282K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,118 |
7,361 |
$278K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
24,528 |
20,165 |
$275K |
| 0750 |
|
3,390 |
1,382 |
$268K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
1,887 |
1,866 |
$267K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,058 |
1,037 |
$266K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14,937 |
10,742 |
$260K |
| 86922 |
|
369 |
221 |
$259K |
| 99218 |
|
1,444 |
1,419 |
$257K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,258 |
4,251 |
$255K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,043 |
3,952 |
$253K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,880 |
3,843 |
$250K |
| V2632 |
Posterior chamber intraocular lens |
1,375 |
1,360 |
$249K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
6,870 |
6,662 |
$244K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
379 |
351 |
$244K |
| 93351 |
|
1,928 |
1,901 |
$237K |
| 88341 |
|
1,574 |
1,490 |
$237K |
| 93975 |
|
3,427 |
3,293 |
$234K |
| 76830 |
Ultrasound, transvaginal |
6,250 |
6,066 |
$232K |
| 97763 |
|
6,555 |
2,324 |
$231K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15,415 |
13,740 |
$231K |
| 72158 |
|
350 |
350 |
$230K |
| 70496 |
|
2,442 |
2,376 |
$227K |
| 93320 |
|
4,188 |
4,124 |
$227K |
| J2350 |
Injection, ocrelizumab, 1 mg |
13 |
12 |
$225K |
| 0370 |
|
3,049 |
2,879 |
$221K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
11,912 |
5,052 |
$214K |
| 70498 |
|
2,866 |
2,798 |
$210K |
| J9310 |
Injection, rituximab, 100 mg |
187 |
70 |
$206K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
26,889 |
22,501 |
$205K |
| 93970 |
|
2,674 |
2,584 |
$205K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,444 |
6,255 |
$203K |
| 76770 |
|
4,394 |
4,267 |
$203K |
| 93247 |
|
1,882 |
1,867 |
$202K |
| 70543 |
|
770 |
760 |
$197K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,880 |
1,163 |
$197K |
| 97139 |
|
8,742 |
1,783 |
$194K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
1,116 |
667 |
$193K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
12,171 |
8,924 |
$191K |
| 49083 |
|
1,972 |
1,064 |
$189K |
| J0485 |
Injection, belatacept, 1 mg |
991 |
275 |
$188K |
| J9306 |
Injection, pertuzumab, 1 mg |
291 |
54 |
$186K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28,338 |
25,499 |
$185K |
| 70486 |
|
2,765 |
2,699 |
$183K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,536 |
1,534 |
$183K |
| 71045 |
Radiologic examination, chest; single view |
20,020 |
18,932 |
$182K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,358 |
5,231 |
$173K |
| 95819 |
|
1,776 |
1,760 |
$171K |
| 93971 |
|
4,092 |
3,925 |
$157K |
| 84703 |
|
46,833 |
43,165 |
$155K |
| A4657 |
Syringe, with or without needle, each |
6,371 |
701 |
$155K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,790 |
5,619 |
$154K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13,358 |
9,513 |
$153K |
| 82962 |
|
41,087 |
26,742 |
$152K |
| 77301 |
|
133 |
132 |
$152K |
| 67113 |
|
266 |
258 |
$149K |
| 84443 |
Thyroid stimulating hormone (TSH) |
18,338 |
15,476 |
$146K |
| 76536 |
|
3,037 |
2,964 |
$144K |
| 74178 |
|
883 |
860 |
$144K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19,370 |
14,768 |
$142K |
| 83735 |
|
31,227 |
22,580 |
$138K |
| 83970 |
|
3,187 |
2,647 |
$137K |
| 80197 |
|
7,349 |
3,355 |
$137K |
| J0490 |
Injection, belimumab, 10 mg |
160 |
73 |
$136K |
| 0250 |
|
7,954 |
4,381 |
$134K |
| 0361 |
|
833 |
632 |
$133K |
| 76937 |
|
2,765 |
2,647 |
$133K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,471 |
736 |
$133K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
2,174 |
2,073 |
$133K |
| 94060 |
|
3,160 |
3,104 |
$132K |
| 99499 |
|
1,178 |
1,010 |
$131K |
| 86850 |
|
21,696 |
19,349 |
$130K |
| 96367 |
|
3,880 |
2,548 |
$128K |
| 73221 |
|
542 |
492 |
$128K |
| 75574 |
|
509 |
507 |
$128K |
| 97165 |
|
2,871 |
2,445 |
$128K |
| 93623 |
|
40 |
40 |
$125K |
| 81001 |
|
79,176 |
69,929 |
$121K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
9,580 |
4,214 |
$119K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,335 |
2,239 |
$118K |
| 86900 |
|
28,386 |
19,874 |
$113K |
| 92522 |
|
988 |
980 |
$106K |
| 72157 |
|
268 |
267 |
$105K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
4,040 |
2,472 |
$105K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,166 |
794 |
$105K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
66 |
66 |
$104K |
| 74174 |
|
774 |
766 |
$104K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,479 |
5,264 |
$101K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
569 |
328 |
$101K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,153 |
1,115 |
$100K |
| 84484 |
|
48,333 |
28,588 |
$100K |
| 82378 |
|
4,345 |
3,291 |
$100K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,583 |
2,936 |
$99K |
| 76642 |
|
1,918 |
1,814 |
$98K |
| 88307 |
|
1,895 |
1,823 |
$98K |
| 54640 |
|
303 |
284 |
$96K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
7,395 |
5,506 |
$95K |
| 86901 |
|
25,737 |
19,722 |
$94K |
| 97802 |
|
637 |
637 |
$94K |
| 95708 |
|
274 |
149 |
$93K |
| 0762 |
|
5,157 |
2,922 |
$93K |
| 96411 |
|
1,953 |
1,237 |
$92K |
| 94729 |
|
2,328 |
2,279 |
$92K |
| 86999 |
|
2,595 |
1,731 |
$91K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,134 |
4,941 |
$90K |
| 36415 |
Collection of venous blood by venipuncture |
31,687 |
24,777 |
$89K |
| 14040 |
|
794 |
783 |
$88K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
308 |
304 |
$88K |
| 95816 |
|
903 |
899 |
$87K |
| 87077 |
|
21,126 |
11,027 |
$87K |
| 87088 |
|
27,421 |
25,040 |
$85K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
4,372 |
4,204 |
$84K |
| 93017 |
|
1,536 |
1,500 |
$83K |
| 99217 |
|
2,414 |
1,667 |
$83K |
| 83690 |
|
38,024 |
34,818 |
$83K |
| 93451 |
|
77 |
70 |
$80K |
| 87799 |
|
1,502 |
1,202 |
$79K |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,660 |
4,302 |
$78K |
| 92523 |
|
847 |
706 |
$78K |
| 93308 |
|
2,096 |
2,004 |
$77K |
| 88342 |
|
2,752 |
2,619 |
$77K |
| J9267 |
Injection, paclitaxel, 1 mg |
4,237 |
1,004 |
$77K |
| 93225 |
|
1,829 |
1,790 |
$77K |
| 88185 |
|
352 |
269 |
$77K |
| 76801 |
|
2,722 |
2,443 |
$77K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
4,864 |
1,069 |
$76K |
| J2323 |
Injection, natalizumab, 1 mg |
154 |
61 |
$74K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,676 |
2,949 |
$74K |
| 87070 |
|
9,301 |
8,492 |
$74K |
| 84100 |
|
24,738 |
17,682 |
$73K |
| 77066 |
Tomosynthesis, mammo |
545 |
543 |
$71K |
| 70487 |
|
1,015 |
1,004 |
$70K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
701 |
694 |
$70K |
| 0761 |
|
1,929 |
1,739 |
$70K |
| 96523 |
|
875 |
772 |
$69K |
| 77065 |
Tomosynthesis, mammo |
661 |
634 |
$69K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
12,163 |
8,444 |
$68K |
| A9562 |
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries |
106 |
102 |
$68K |
| J9045 |
Injection, carboplatin, 50 mg |
2,442 |
1,186 |
$68K |
| 70546 |
|
182 |
181 |
$68K |
| 74160 |
|
317 |
316 |
$67K |
| 96368 |
|
2,606 |
1,629 |
$67K |
| 85730 |
|
32,591 |
30,313 |
$65K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
2,543 |
788 |
$65K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
9,142 |
8,137 |
$65K |
| 94726 |
|
1,749 |
1,712 |
$65K |
| 87497 |
|
1,175 |
904 |
$63K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
797 |
759 |
$62K |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
1,759 |
1,279 |
$62K |
| 93656 |
|
26 |
26 |
$62K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
6,200 |
3,762 |
$61K |
| 82805 |
|
3,686 |
3,330 |
$60K |
| 73630 |
|
6,149 |
5,400 |
$60K |
| 87430 |
|
6,588 |
6,257 |
$59K |
| 83880 |
|
8,814 |
8,173 |
$59K |
| 72131 |
|
973 |
964 |
$58K |
| A9270 |
Non-covered item or service |
42,761 |
8,951 |
$58K |
| 99224 |
|
826 |
824 |
$58K |
| 78306 |
|
481 |
472 |
$58K |
| 85610 |
|
36,214 |
32,926 |
$58K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
4,089 |
3,779 |
$57K |
| 97803 |
|
801 |
794 |
$57K |
| 72146 |
|
235 |
235 |
$56K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
3,718 |
2,731 |
$55K |
| 73610 |
|
5,222 |
4,691 |
$54K |
| 73130 |
|
5,677 |
5,010 |
$54K |
| 78264 |
|
238 |
229 |
$54K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,500 |
1,407 |
$53K |
| 86945 |
|
875 |
444 |
$50K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
344 |
333 |
$50K |
| 93243 |
|
439 |
439 |
$49K |
| 74170 |
|
294 |
291 |
$48K |
| 76942 |
|
742 |
727 |
$47K |
| 75561 |
|
146 |
146 |
$46K |
| 97166 |
|
1,122 |
957 |
$46K |
| 76641 |
|
659 |
466 |
$45K |
| 96402 |
|
1,608 |
1,511 |
$45K |
| 73564 |
|
4,336 |
3,747 |
$44K |
| 93880 |
|
442 |
429 |
$43K |
| 74018 |
|
6,309 |
5,941 |
$43K |
| 83615 |
|
6,182 |
4,320 |
$43K |
| 93312 |
|
407 |
403 |
$42K |
| J3480 |
Injection, potassium chloride, per 2 meq |
4,226 |
2,182 |
$42K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
1,118 |
330 |
$41K |
| J9070 |
Cyclophosphamide, 100 mg |
142 |
62 |
$41K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
484 |
383 |
$40K |
| 96377 |
|
1,786 |
1,278 |
$40K |
| G0378 |
Hospital observation service, per hour |
5,133 |
3,094 |
$39K |
| C9399 |
Unclassified drugs or biologicals |
321 |
315 |
$38K |
| 82728 |
|
3,971 |
3,592 |
$38K |
| 77338 |
|
135 |
132 |
$38K |
| 77062 |
|
203 |
203 |
$37K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
390 |
384 |
$37K |
| 36561 |
|
154 |
147 |
$37K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
4,215 |
1,114 |
$36K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,451 |
1,006 |
$35K |
| 84702 |
|
5,535 |
4,729 |
$35K |
| 86833 |
|
1,066 |
1,013 |
$35K |
| 73030 |
|
4,250 |
3,829 |
$35K |
| 73110 |
|
3,599 |
3,261 |
$34K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,891 |
3,598 |
$34K |
| 83605 |
|
13,439 |
11,241 |
$34K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,164 |
6,015 |
$33K |
| 72100 |
|
2,963 |
2,832 |
$33K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,888 |
6,385 |
$33K |
| 86832 |
|
1,087 |
1,026 |
$33K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,955 |
1,222 |
$33K |
| 93454 |
|
53 |
52 |
$33K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
11,856 |
10,133 |
$32K |
| 82330 |
|
4,413 |
3,943 |
$31K |
| 76776 |
|
739 |
688 |
$31K |
| 76813 |
|
470 |
463 |
$31K |
| 99225 |
|
451 |
450 |
$31K |
| 84439 |
|
4,552 |
4,024 |
$31K |
| J2785 |
Injection, regadenoson, 0.1 mg |
339 |
336 |
$30K |
| 74240 |
|
398 |
379 |
$30K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,096 |
1,540 |
$30K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
507 |
475 |
$29K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
940 |
882 |
$29K |
| G0277 |
Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval |
230 |
13 |
$29K |
| 93246 |
|
1,885 |
1,870 |
$29K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,722 |
3,505 |
$28K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,629 |
1,970 |
$28K |
| 82570 |
|
5,018 |
2,851 |
$28K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
1,976 |
1,231 |
$27K |
| 88304 |
|
1,865 |
1,848 |
$27K |
| 76870 |
|
1,537 |
1,448 |
$27K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
4,832 |
4,549 |
$27K |
| 85007 |
|
11,751 |
9,397 |
$26K |
| 67042 |
|
26 |
26 |
$25K |
| 73700 |
|
313 |
296 |
$25K |
| 0272 |
|
11,954 |
9,628 |
$24K |
| 73590 |
|
4,090 |
3,536 |
$24K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,494 |
1,421 |
$23K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
1,413 |
896 |
$23K |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
2,102 |
1,211 |
$23K |
| 84550 |
|
4,601 |
3,116 |
$23K |
| 90715 |
|
2,466 |
2,392 |
$23K |
| 90791 |
Psychiatric diagnostic evaluation |
138 |
137 |
$23K |
| 94618 |
|
940 |
922 |
$22K |
| 72128 |
|
477 |
474 |
$22K |
| 90832 |
Psychotherapy, 30 minutes with patient |
363 |
330 |
$22K |
| T1024 |
Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter |
186 |
159 |
$21K |
| 74220 |
|
671 |
642 |
$21K |
| 43762 |
|
530 |
508 |
$21K |
| 73090 |
|
3,895 |
3,432 |
$21K |
| 96401 |
|
245 |
90 |
$21K |
| C1769 |
Guide wire |
1,067 |
930 |
$21K |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
10,814 |
2,397 |
$21K |
| 73080 |
|
2,800 |
2,587 |
$20K |
| 87536 |
|
398 |
393 |
$20K |
| 87147 |
|
7,401 |
2,466 |
$20K |
| 73562 |
|
2,269 |
1,889 |
$20K |
| 10060 |
|
975 |
931 |
$20K |
| 86300 |
|
1,477 |
729 |
$20K |
| 74328 |
|
103 |
102 |
$19K |
| 95813 |
|
235 |
226 |
$19K |
| 87040 |
|
8,082 |
4,958 |
$19K |
| 30140 |
|
237 |
138 |
$19K |
| 85347 |
|
1,479 |
844 |
$19K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,788 |
944 |
$18K |
| 77470 |
|
162 |
154 |
$18K |
| 86301 |
|
1,037 |
798 |
$18K |
| 78709 |
|
83 |
83 |
$18K |
| 80061 |
Lipid panel |
2,369 |
2,250 |
$18K |
| 88184 |
|
361 |
282 |
$18K |
| 83550 |
|
3,090 |
2,846 |
$18K |
| 86803 |
|
1,379 |
1,279 |
$17K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
195 |
169 |
$17K |
| 97161 |
|
948 |
892 |
$17K |
| 86304 |
|
918 |
779 |
$17K |
| J9190 |
Injection, fluorouracil, 500 mg |
714 |
377 |
$17K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
132 |
131 |
$16K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
28 |
24 |
$16K |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
480 |
210 |
$16K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
342 |
188 |
$16K |
| 84132 |
|
6,421 |
5,540 |
$16K |
| P9041 |
Infusion, albumin (human), 5%, 50 ml |
89 |
51 |
$16K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,016 |
931 |
$16K |
| 0681 |
|
21 |
21 |
$16K |
| C1771 |
Repair device, urinary, incontinence, with sling graft |
12 |
12 |
$15K |
| 73502 |
|
1,252 |
1,202 |
$15K |
| 87340 |
|
1,921 |
1,754 |
$15K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,143 |
1,326 |
$15K |
| 30520 |
|
210 |
189 |
$15K |
| 87205 |
|
4,465 |
3,773 |
$14K |
| C1874 |
Stent, coated/covered, with delivery system |
12 |
12 |
$14K |
| A4913 |
Miscellaneous dialysis supplies, not otherwise specified |
877 |
204 |
$14K |
| 0459 |
|
1,174 |
1,123 |
$14K |
| 84156 |
|
3,963 |
2,083 |
$14K |
| J9075 |
Injection, cyclophosphamide, not otherwise specified, 5 mg |
324 |
63 |
$14K |
| 76604 |
|
1,263 |
1,214 |
$14K |
| 77321 |
|
142 |
127 |
$13K |
| 87186 |
|
2,370 |
2,063 |
$13K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,153 |
1,040 |
$13K |
| 72070 |
|
1,137 |
1,082 |
$13K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
416 |
415 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
696 |
676 |
$12K |
| 87390 |
|
960 |
945 |
$12K |
| 73552 |
|
2,105 |
1,864 |
$12K |
| 96376 |
|
2,727 |
2,071 |
$12K |
| 85018 |
|
6,170 |
5,544 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,332 |
2,240 |
$12K |
| 77001 |
|
148 |
148 |
$12K |
| 86140 |
|
7,371 |
6,806 |
$12K |
| 43235 |
|
163 |
155 |
$12K |
| 97116 |
|
2,479 |
1,137 |
$11K |
| J1940 |
Injection, furosemide, up to 20 mg |
2,042 |
1,589 |
$11K |
| 93505 |
|
31 |
29 |
$11K |
| 87522 |
Neg quan hep c or qual rna |
233 |
228 |
$11K |
| 73060 |
|
2,349 |
2,148 |
$11K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
711 |
413 |
$11K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
51 |
51 |
$11K |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
579 |
468 |
$11K |
| J2720 |
Injection, protamine sulfate, per 10 mg |
602 |
467 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
819 |
518 |
$10K |
| 94010 |
|
551 |
544 |
$10K |
| 36591 |
|
614 |
371 |
$10K |
| 93356 |
|
234 |
233 |
$10K |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
90 |
86 |
$10K |
| 72040 |
|
1,095 |
1,035 |
$10K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
723 |
426 |
$10K |
| 82810 |
|
765 |
525 |
$9K |
| 82105 |
|
197 |
173 |
$9K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
209 |
198 |
$9K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,520 |
1,469 |
$9K |
| 87210 |
|
3,882 |
3,748 |
$9K |
| 86706 |
|
999 |
906 |
$9K |
| 86702 |
|
990 |
974 |
$9K |
| 30465 |
|
20 |
14 |
$9K |
| 87517 |
|
159 |
155 |
$9K |
| J2060 |
Injection, lorazepam, 2 mg |
2,413 |
2,019 |
$9K |
| 0760 |
|
392 |
355 |
$9K |
| 85379 |
|
2,491 |
2,361 |
$9K |
| 82550 |
|
5,222 |
4,279 |
$8K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,219 |
907 |
$8K |
| 87102 |
|
841 |
689 |
$8K |
| 76882 |
|
983 |
921 |
$8K |
| 0270 |
|
8,321 |
6,891 |
$8K |
| 73140 |
|
591 |
558 |
$8K |
| 82248 |
|
1,393 |
1,234 |
$8K |
| 82607 |
|
655 |
619 |
$8K |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
503 |
483 |
$8K |
| 75572 |
|
53 |
53 |
$8K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
56 |
56 |
$7K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
1,186 |
991 |
$7K |
| 88313 |
|
193 |
186 |
$7K |
| 89051 |
|
1,065 |
965 |
$7K |
| 84520 |
|
2,776 |
2,212 |
$7K |
| 74022 |
|
1,338 |
1,293 |
$7K |
| 82784 |
|
984 |
494 |
$7K |
| J9206 |
Injection, irinotecan, 20 mg |
289 |
103 |
$7K |
| J1171 |
Injection, hydromorphone, 0.1 mg |
328 |
182 |
$7K |
| 72170 |
|
1,730 |
1,685 |
$7K |
| 87075 |
|
568 |
503 |
$7K |
| 86701 |
|
990 |
974 |
$7K |
| 82435 |
|
3,575 |
3,264 |
$6K |
| 93242 |
|
439 |
439 |
$6K |
| 84145 |
|
1,980 |
1,864 |
$6K |
| 85652 |
|
6,392 |
6,017 |
$6K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
753 |
639 |
$6K |
| 71270 |
|
161 |
150 |
$6K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
119 |
108 |
$6K |
| 84295 |
|
3,695 |
3,360 |
$6K |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
714 |
192 |
$6K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
174 |
105 |
$6K |
| 36430 |
|
136 |
98 |
$6K |
| 78451 |
|
15 |
15 |
$6K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
326 |
256 |
$6K |
| 76000 |
|
24 |
24 |
$6K |
| 88331 |
|
232 |
227 |
$5K |
| 82247 |
|
732 |
635 |
$5K |
| 92610 |
|
274 |
271 |
$5K |
| 88350 |
|
13 |
12 |
$5K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
508 |
490 |
$5K |
| 0259 |
|
10,143 |
5,118 |
$5K |
| A4315 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone |
92 |
91 |
$5K |
| 86704 |
|
626 |
548 |
$5K |
| 77075 |
|
491 |
476 |
$5K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
61 |
53 |
$5K |
| 82274 |
|
1,141 |
1,099 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
100 |
90 |
$5K |
| 62270 |
|
120 |
107 |
$5K |
| 70480 |
|
42 |
42 |
$5K |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
420 |
413 |
$5K |
| 92526 |
|
75 |
40 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,160 |
1,035 |
$5K |
| 93321 |
|
207 |
197 |
$5K |
| 97162 |
|
255 |
245 |
$5K |
| 12001 |
|
661 |
643 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,556 |
2,415 |
$4K |
| 70481 |
|
44 |
43 |
$4K |
| 86593 |
|
1,479 |
1,452 |
$4K |
| 90839 |
|
941 |
895 |
$4K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
348 |
236 |
$4K |
| 73100 |
|
773 |
697 |
$4K |
| 82553 |
|
2,318 |
1,568 |
$4K |
| 73560 |
|
569 |
492 |
$4K |
| A4217 |
Sterile water/saline, 500 ml |
969 |
773 |
$4K |
| 86334 |
|
186 |
166 |
$4K |
| 82746 |
|
319 |
307 |
$4K |
| 82150 |
|
1,567 |
1,384 |
$4K |
| 58571 |
|
13 |
13 |
$4K |
| 61782 |
|
41 |
39 |
$4K |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
368 |
360 |
$4K |
| J3489 |
Injection, zoledronic acid, 1 mg |
139 |
129 |
$4K |
| 82310 |
|
434 |
304 |
$4K |
| 0296T |
|
404 |
390 |
$4K |
| L2112 |
Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment |
25 |
25 |
$4K |
| 73720 |
|
12 |
12 |
$3K |
| 84153 |
|
300 |
285 |
$3K |
| 87184 |
|
1,234 |
1,121 |
$3K |
| 78018 |
|
14 |
14 |
$3K |
| 83521 |
|
302 |
138 |
$3K |
| A9573 |
Injection, gadopiclenol, 1 ml |
150 |
147 |
$3K |
| 31267 |
|
18 |
12 |
$3K |
| 86480 |
|
185 |
178 |
$3K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
283 |
153 |
$3K |
| 86902 |
|
55 |
40 |
$3K |
| 83520 |
|
259 |
133 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
19 |
19 |
$3K |
| 85046 |
|
852 |
667 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
672 |
466 |
$3K |
| 10005 |
|
58 |
58 |
$3K |
| 82108 |
|
331 |
264 |
$3K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
78 |
15 |
$3K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
2,070 |
1,944 |
$3K |
| 82010 |
|
1,355 |
1,227 |
$3K |
| 93662 |
|
24 |
24 |
$3K |
| 73501 |
|
537 |
512 |
$2K |
| 64642 |
|
38 |
38 |
$2K |
| 73070 |
|
807 |
705 |
$2K |
| 91010 |
|
56 |
56 |
$2K |
| 54360 |
|
24 |
24 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,372 |
1,215 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
957 |
628 |
$2K |
| 93613 |
|
27 |
27 |
$2K |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
168 |
154 |
$2K |
| 86769 |
|
51 |
48 |
$2K |
| J2252 |
Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg |
116 |
111 |
$2K |
| 51702 |
|
312 |
289 |
$2K |
| 12011 |
|
355 |
339 |
$2K |
| 80299 |
|
243 |
215 |
$2K |
| 85384 |
|
317 |
289 |
$2K |
| J1836 |
Injection, metronidazole, 10 mg |
161 |
143 |
$2K |
| 51701 |
|
142 |
137 |
$2K |
| 58661 |
|
13 |
13 |
$2K |
| 64643 |
|
85 |
81 |
$2K |
| J9171 |
Injection, docetaxel, 1 mg |
61 |
25 |
$2K |
| 88300 |
|
450 |
435 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
59 |
58 |
$2K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
607 |
561 |
$2K |
| 86308 |
|
852 |
783 |
$2K |
| 86762 |
|
135 |
105 |
$2K |
| 84165 |
|
181 |
163 |
$2K |
| 80143 |
|
1,886 |
1,786 |
$2K |
| 43760 |
|
63 |
60 |
$2K |
| 70355 |
|
312 |
306 |
$2K |
| 57288 |
|
24 |
24 |
$2K |
| J1953 |
Injection, levetiracetam, 10 mg |
187 |
146 |
$1K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
96 |
51 |
$1K |
| 77080 |
|
40 |
40 |
$1K |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
196 |
185 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
599 |
498 |
$1K |
| 86592 |
|
477 |
460 |
$1K |
| 70250 |
|
156 |
140 |
$1K |
| 74019 |
|
564 |
542 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
135 |
125 |
$1K |
| 87116 |
|
126 |
95 |
$1K |
| 71100 |
|
54 |
53 |
$1K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
166 |
88 |
$1K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
15 |
12 |
$1K |
| 93923 |
|
13 |
13 |
$1K |
| 49500 |
|
17 |
12 |
$1K |
| 88112 |
|
26 |
25 |
$1K |
| 73521 |
|
84 |
84 |
$1K |
| 86870 |
|
42 |
37 |
$1K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
13 |
12 |
$1K |
| 86235 |
|
77 |
77 |
$1K |
| 82140 |
|
377 |
341 |
$1K |
| 90686 |
|
105 |
103 |
$1K |
| 0258 |
|
1,675 |
1,059 |
$994.47 |
| 74230 |
|
26 |
26 |
$993.50 |
| 62328 |
|
12 |
12 |
$983.12 |
| 50200 |
|
27 |
27 |
$943.39 |
| 0271 |
|
1,673 |
1,419 |
$935.63 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
353 |
117 |
$928.93 |
| 88173 |
|
38 |
38 |
$926.34 |
| 97003 |
|
23 |
12 |
$906.62 |
| 93924 |
|
12 |
12 |
$825.71 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
46 |
42 |
$818.28 |
| 20680 |
|
15 |
12 |
$812.00 |
| 83020 |
|
74 |
51 |
$807.04 |
| 93319 |
|
15 |
15 |
$781.14 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
46 |
42 |
$775.94 |
| 87206 |
|
162 |
130 |
$771.24 |
| 73200 |
|
15 |
15 |
$771.01 |
| 71020 |
|
168 |
164 |
$724.45 |
| 97018 |
|
303 |
119 |
$704.39 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
35 |
14 |
$689.15 |
| 84460 |
|
358 |
351 |
$653.72 |
| 88360 |
|
28 |
25 |
$647.72 |
| 84450 |
|
360 |
354 |
$639.62 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
106 |
96 |
$632.49 |
| 99195 |
|
32 |
24 |
$630.35 |
| 82977 |
|
45 |
45 |
$624.51 |
| 80074 |
|
12 |
12 |
$536.08 |
| 93797 |
|
24 |
13 |
$535.04 |
| 84403 |
|
28 |
27 |
$513.13 |
| 82945 |
|
282 |
267 |
$508.29 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
175 |
114 |
$502.12 |
| 88311 |
|
193 |
192 |
$501.16 |
| 80076 |
|
130 |
123 |
$498.05 |
| 84157 |
|
294 |
281 |
$484.36 |
| 86780 |
|
83 |
81 |
$406.46 |
| 36224 |
|
13 |
12 |
$403.13 |
| 82525 |
|
29 |
26 |
$309.19 |
| 84478 |
|
72 |
62 |
$288.81 |
| 84630 |
|
33 |
28 |
$279.91 |
| 84255 |
|
16 |
12 |
$256.20 |
| 64644 |
|
21 |
18 |
$240.00 |
| 86318 |
|
105 |
104 |
$230.01 |
| 94760 |
|
27 |
26 |
$228.27 |
| 86787 |
|
24 |
14 |
$227.58 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
1,142 |
1,034 |
$225.53 |
| 94770 |
|
37 |
36 |
$224.37 |
| 97026 |
|
140 |
54 |
$223.16 |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
13 |
12 |
$222.80 |
| 88346 |
|
12 |
12 |
$222.00 |
| 88302 |
|
27 |
27 |
$208.57 |
| 87106 |
|
27 |
27 |
$201.00 |
| 0042T |
|
88 |
88 |
$197.85 |
| J1120 |
Injection, acetazolamide sodium, up to 500 mg |
12 |
12 |
$193.19 |
| 12002 |
|
126 |
119 |
$186.80 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
1,807 |
1,622 |
$183.29 |
| 82365 |
|
14 |
12 |
$182.93 |
| 86735 |
|
14 |
14 |
$176.48 |
| 86765 |
|
14 |
14 |
$174.30 |
| 86665 |
|
27 |
13 |
$154.80 |
| 73620 |
|
13 |
13 |
$154.38 |
| 87045 |
|
42 |
40 |
$150.34 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
39 |
29 |
$148.67 |
| 73660 |
|
14 |
12 |
$130.80 |
| J2359 |
Injection, olanzapine, 0.5 mg |
37 |
28 |
$123.78 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
13 |
13 |
$123.41 |
| 86777 |
|
12 |
12 |
$121.62 |
| 86644 |
|
12 |
12 |
$117.72 |
| 70360 |
|
40 |
39 |
$108.35 |
| 74000 |
|
52 |
48 |
$108.03 |
| 73000 |
|
33 |
31 |
$98.17 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
12 |
$92.86 |
| 87427 |
|
27 |
26 |
$92.70 |
| 81003 |
|
337 |
319 |
$92.14 |
| 31720 |
|
114 |
97 |
$85.12 |
| 82043 |
|
12 |
12 |
$75.42 |
| 71010 |
|
28 |
24 |
$74.45 |
| 36600 |
|
14 |
14 |
$73.69 |
| 0621 |
|
16 |
13 |
$71.75 |
| 86664 |
|
13 |
12 |
$68.22 |
| 85651 |
|
157 |
153 |
$67.31 |
| 87324 |
|
12 |
12 |
$66.16 |
| 87449 |
|
12 |
12 |
$66.16 |
| 86663 |
|
13 |
12 |
$60.31 |
| 0100U |
|
91 |
90 |
$55.12 |
| 80164 |
|
57 |
53 |
$43.27 |
| 87185 |
|
28 |
25 |
$37.99 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
16 |
16 |
$34.49 |
| 76010 |
|
14 |
14 |
$25.40 |
| A6453 |
Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard |
192 |
152 |
$2.62 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
101 |
53 |
$0.01 |
| 0637 |
|
1,070 |
521 |
$0.00 |
| C1758 |
Catheter, ureteral |
30 |
26 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
14 |
12 |
$0.00 |
| 77076 |
|
12 |
12 |
$0.00 |
| 94664 |
|
17 |
12 |
$0.00 |
| 85396 |
|
12 |
12 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
20 |
13 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
55 |
49 |
$0.00 |
| 80320 |
|
78 |
77 |
$0.00 |
| 0636 |
|
37 |
34 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
20 |
20 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
17 |
17 |
$0.00 |